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Summary
Introduction:  Maxillary  bone  myxoma  is  a  rare  benign  mesenchymal  tumor,  slow-growing  but
locally aggressive.  Pathogenesis  remains  disputed.
Objective:  To  study  the  clinical,  radiological  and  histological  features  and  treatment  of  maxil-
lary myxoma,  based  on  a  pediatric  case  report.
Case report:  An  infant  of  two  and  a  half  months  presented  with  endonasal  tumor  extending  to
ethmoid. Surgical  excision  was  performed  on  an  endonasal  approach.  Myxoma  was  diagnosed
by histologic  examination  of  the  surgical  specimen,  whereas  initial  biopsy  had  suggested  ﬁbrous
dysplasia.  No  recurrence  was  observed  after  two  and  a  half  years’  surveillance.
Conclusion:  Positive  diagnosis  of  maxillary  myxoma  is  histological.  Treatment  is  primarily  sur-
gical. Strict  long-term  surveillance  is  required  because  of  the  high  risk  of  recurrence.
© 2013  Published  by  Elsevier  Masson  SAS.
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Maxillary  myxoma  is  a  benign  tumor,  slow-growing  but  locally
aggressive.  It  represents  3  to  7%  of  odontogenic  tumors  and
0.41%  of  osseous  tumors  [1].
Pathogenesis  is  disputed;  both  bone  and  soft  tissue  may
be  involved  [1].
Sporadic  cases  have  been  reported  [2,3].  Treatment  is
surgical.
Case reportA  two-and-a-half  month-old  infant  without  previous  his-
tory  presented  with  left  nasal  obstruction  of  1  month’s
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http://dx.doi.org/10.1016/j.anorl.2013.04.004volution,  with  associated  ipsilateral  rhinorrhea.  Endonasal
xamination  in  consultation  found  a  ﬂeshy,  non-hemorrhagic
ormation  obstructing  the  left  nasal  cavity,  deforming  the
asal  wing  and  pushing  the  septum  rightward.  The  cavum
as  free.  Oral  and  oropharyngeal  examination  was  normal.
ervical  examination  found  no  adenopathies.  Ophthalmo-
ogical  and  neurological  examination  was  normal.
CT  found  a  left  ethmoid-nasal  mass  with  heterogeneous
ptake,  pushing  the  nasal  septum  and  causing  lysis  of  the
ntersinonasal  wall  and  lamina  papyracea,  with  intra-orbital
xtension,  and  lysis  of  the  nasal  bone  and  ethmoid  roof,  with
ndocranial  extension  (Fig.  1).  There  was  bony  palate  lysis
elow.
MRI  showed  the  mass  in  hyposignal  on  T1  and  slightly
eterogeneous  hypersignal  on  T2-weighted  sequences,  with
eterogeneous  gadolinium  uptake,  touching  the  internal
all  of  the  orbit  and  pushing  back  the  rectus  medi-
lis,  without  signs  of  intra-orbital  or  endocranial  invasion
Figs.  2,  3).
.
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Figure  1  Facial  bone  CT,  axial  slice.
Figure  2  T2-weighted  MRI,  coronal  slice.
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is  very  poorly  vascularized.  Odontogenic  epithelium  is  not  a
necessary  condition  for  diagnosis,  although  indicating  dental
origin  according  to  certain  reports;  it  raises  the  question  ofFibrous  dysplasia  was  initially  diagnosed  after  pathologic
xamination  of  a  biopsy  sample.
The  child  was  operated  via  an  endonasal  approach.  Per-
perative  inspection  found  a  highly  friable  tissular  formation
ith  an  osteocartilaginous  component.  Complete  resection
as  performed.  Deﬁnitive  histology  diagnosed  myxoma,  in
he  light  of  spindle  and  stellate  cells  without  cellular  atypia,
eparated  by  a  poorly  vascularized  myxoid  matrix  inﬁltrat-
ng  adjacent  bone  structures.  There  was  no  odontogenic
pithelium.
Postoperative  course  was  straightforward,  with  no  recur-
ence  at  two  and  a  half  years’  follow-up.igure  3  T1-weighted  gadolinium-enhanced  MRI,  coronal
lice.
iscussion
yxoma  was  ﬁrst  described  by  Virchow  in  1863  [3].  It  is  of
esenchymatous  origin  and  usually  concerns  adolescents  or
oung  adults  [1,2];  it  is  rarer  in  children  and  infants.
Some  authors  reported  no  sex  predominance;  others
ound  a  slight  female  predominance  [4].
Pathogenesis  is  obscure.  Two  hypotheses  have  been  sug-
ested:  tumoral  development  in  residual  conjunctive  tissue
tem  cells,  or  myxomatous  degeneration  of  the  ﬁbrous
troma  [5].
Myxoma  is  slow-growing.  It  becomes  symptomatic  only
hen  large,  with  pain  or  facial  deformity.
Imaging  guides  diagnosis,  determining  site  and  extension.
CT  ﬁnds  a  multi-cystic  bone  lesion  with  cortical  thick-
ning,  containing  septa  within  a  mass  of  tissue-like  density.
hen  non-encapsulated,  the  lesion  appears  to  be  inﬁltrating
6].
On  MRI,  myxoma  shows  in  hyposignal  on  T1  and  hyper-
ignal  on  T2-weighted  sequences.  This  aspect  is  highly
uggestive,  but  not  systematic.  Enhancement  on  contrast-
edium  injection  is  variable  [3,7].
Imaging  is  useful  for  differential  diagnosis,  ruling  out
esions  in  which  biopsy  would  be  dangerous:  endonasal
emangioma,  meningocele  or  meningoencephalocele,  or
lial  heterotopy  [7,8].  Positive  diagnosis  relies  on  pathologic
xamination  of  the  surgical  specimen.  Myxoma  is  charac-
erized  by  ovoid,  stellate  and  spindle  cells  scattered  in
bundant  mucoid  stroma  and  in  a  network  of  reticulated
bers.  There  is  no  atypia;  mitotic  activity  is  weak.  Myxoma
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differential  diagnosis  with  respect  to  myxoid  liposarcoma,
rhabdomyosarcoma  and  ﬁbroblastic  or  chondroid  tumor  [3].
Immunohistochemistry  ﬁnds  tumor  cells  expressing
vimentin  but  not  cytokeratin,  neuron-speciﬁc  enolase  (NSE),
glial  ﬁbrillary  acid  protein  (GFAP),  neuroﬁlaments,  desmin
or  factor  VIII  [3].
The  interest  of  tumoral  biopsy  is  debatable.  As  seen  in
the  present  case,  the  biopsy  fragment  usually  does  not  show
pathognomic  signs,  as  the  tumor  contains  several  myxoid
zones  [3].
Treatment  is  surgical.
Wide  resection  with  10  to  15  mm  margins  is  generally  rec-
ommended,  in  view  of  the  aggressiveness  and  recurrence
rate  associated  with  myxoma  [3].
According  to  some  authors,  however,  simple  enucleation
or  curettage  may  be  sufﬁcient.  W.  Rotenberg  et  al.  reported
no  recurrence  at  a  mean  8.5  years’  follow-up  in  maxillary
myxoma  resected  without  margins  [9].  In  the  present  pedi-
atric  case,  there  was  no  recurrence  at  2.5  years’  follow-up,
although  complete  resection  did  not  include  wide  margins.
According  to  some  authors,  however,  this  attitude  accounts
for  the  observed  25%  recurrence  rate  [3].
The  choice  of  approach  depends  on  site  and  extension.
In  certain  large  tumors  treated  by  broad  resection  and
maxillectomy,  there  is  signiﬁcant  loss  of  substance;  repair
depends  on  how  much:  if  less  than  5  cm,  immediate  repair
using  bone  graft,  regional  rotation  ﬂap  or  remote  ﬂaps  is  pos-
sible;  if  more  than  5  cm,  obturator  prostheses  are  required.
Free-ﬂap  repair  has  also  been  recommended  [10].
Myxoma  is  associated  with  a  high  rate  of  recurrence,
due  to  its  gelatinous  nature  and  the  absence  of  a  capsule;
prolonged  clinical  and  radiological  surveillance  is  therefore
mandatory  [2].  Time  to  recurrence  ranges  from  2  to  15  years
[3].Conclusion
Maxillary  myxoma  is  a  benign  but  locally  aggressive
tumor.  Positive  diagnosis  is  founded  on  histologic  specimen
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nalysis.  Treatment  is  surgical.  Strict  prolonged  surveillance
s  required  due  to  the  risk  of  recurrence.
isclosure of interest
he  authors  declare  that  they  have  no  conﬂicts  of  interest
oncerning  this  article.
eferences
[1] Bayi E, El Hartiet K, et al. Myxome odontogène des maxillaires.
Rev Stomatol Chir Maxillofac 2006;107:389—92.
[2] Gassab I, Hamroun A, et al. Myxome du maxillaire : à propos
d’un cas. J Tun ORL 2007;18:44—5.
[3] Kourda-Boujemaa J, Farah-Klibi F, et al. Le myxome odon-
togénique : étude de quatre cas et revue de la littérature. Ann
Pathol 2010;30:168—75.
[4] Mosqueda-Taylor A, Ledesma-Montes C, Caballero-Sandoval S,
et al. Odontogenic tumors in Mexico: a collaborative retro-
spective study of 349 cases. Oral Surg Oral Med Oral Pathol
1997;84:672—5.
[5] Jankowski M, Yeung R, Lee KM, et al. Odontogenic myxoma
in the Hong Kong Chinese: clinico-radiological presenta-
tion and systemic review. Dentomaxillofac Radiol 2001;31:
71—83.
[6] Asaumi J, Konouchi H, Hisatomi M, et al. Odontogenic myxoma
of maxillary sinus: CT and MR — pathologic correlation. Eur J
Radiol 2001;37:1—4.
[7] Mukerji Shraddha S, Parmar Hemant A, Gujar S, et al. Intranasal
meningoencephalocele presenting as a nasal polyp. A case
report. Clin Imaging 2011;35:309—11.
[8] Riffaud L, Ndikumana R, Azzis O, et al. Glial heterotopia of the
face. J Pediatr Surg 2008;43:1—3.
[9] W Rotenberg B, J Daniel S, A Nish I, et al. Myxoma-
tous lesions of the maxilla in children: a case series and
review of management. Int J Pediatr Otorhinolaryngol 2004;68:10] Leiser Y, Abu-El-Naaj I, Peled M. Odontogenic myxoma - A case
series and review of the surgical management. J Craniomax-
illofac Surg 2009;37:206—9.
